Fierce Biotech1 min read
saveLundbeck plans US headquarters move to Boston to boost neuroscience R&D
read at Fierce Biotech ↗Neutral
Lundbeck, a Danish pharmaceutical company focused on neuroscience, announced it will relocate its U.S. operations to Boston.
The move is part of a broader strategy to concentrate R&D on increasingly specialized neuroscience targets, leveraging Boston's dense biopharma ecosystem.
By establishing its U.S. headquarters in a leading biotech hub, Lundbeck aims to accelerate innovation and collaboration with academic and industry partners.
source
This writeup was produced by pharmadog from original reporting by Fierce Biotech.
Original headline: “Lundbeck to move US digs to Boston as it eyes bigger innovation frontiers”
read at Fierce Biotech ↗
comments(0)
5-min edit window · permanent after that